VIETRI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.498
EU - Europa 2.297
AS - Asia 1.324
SA - Sud America 242
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 95
OC - Oceania 8
Totale 6.625
Nazione #
US - Stati Uniti d'America 2.432
IT - Italia 669
RU - Federazione Russa 493
SG - Singapore 416
CN - Cina 318
GB - Regno Unito 316
IE - Irlanda 247
BR - Brasile 210
VN - Vietnam 148
HK - Hong Kong 137
DE - Germania 127
SE - Svezia 115
FR - Francia 99
IN - India 64
FI - Finlandia 55
ZA - Sudafrica 55
BD - Bangladesh 44
UA - Ucraina 43
KR - Corea 38
CA - Canada 34
IQ - Iraq 30
ES - Italia 27
ID - Indonesia 25
JP - Giappone 24
NL - Olanda 23
MX - Messico 18
CZ - Repubblica Ceca 16
PL - Polonia 16
EG - Egitto 14
SA - Arabia Saudita 14
TR - Turchia 14
PK - Pakistan 13
BE - Belgio 11
AR - Argentina 8
AU - Australia 8
IR - Iran 8
AT - Austria 7
CI - Costa d'Avorio 7
EC - Ecuador 7
HR - Croazia 7
BG - Bulgaria 6
KE - Kenya 6
PY - Paraguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
CM - Camerun 4
LT - Lituania 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
JM - Giamaica 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
DZ - Algeria 2
IL - Israele 2
LV - Lettonia 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 6.465
Città #
Dallas 404
Southend 254
Singapore 244
Dublin 243
Ashburn 203
Moscow 160
Santa Clara 153
Fairfield 147
San Jose 147
Milan 138
Chandler 130
Hong Kong 123
Beijing 110
Council Bluffs 72
New York 68
Seattle 58
Siena 57
Wilmington 56
Woodbridge 55
Houston 54
Lastra a Signa 54
Johannesburg 50
Los Angeles 45
Rome 45
Helsinki 42
Cambridge 41
Ho Chi Minh City 41
Hefei 37
Munich 35
Princeton 34
Jacksonville 31
Lauterbourg 30
Hanoi 28
Columbus 24
Ann Arbor 22
Seoul 22
São Paulo 21
Buffalo 20
Figino 20
Florence 20
Chicago 18
Gavirate 18
Redondo Beach 18
Shanghai 18
San Mateo 17
The Dalles 17
Tokyo 17
Fremont 16
Haiphong 16
Málaga 16
Nuremberg 16
Dearborn 15
Orem 15
Baghdad 12
Boardman 12
Brno 12
Warsaw 12
Frankfurt am Main 11
Hanover 11
Jeddah 11
Montreal 11
Phoenix 11
Comun Nuovo 10
Denver 10
London 10
Boston 9
Brescia 9
Brooklyn 9
Chennai 9
Da Nang 9
Jakarta 9
San Diego 9
Toronto 9
Bengaluru 8
Mexico City 8
Mumbai 8
Paris 8
Abidjan 7
Atlanta 7
Cagliari 7
Manchester 7
Padova 7
Piscataway 7
Portsmouth 7
Rio de Janeiro 7
Stockholm 7
Anagni 6
Belo Horizonte 6
Brussels 6
Dhaka 6
Lappeenranta 6
Turin 6
Turku 6
Washington 6
Agliana 5
Bologna 5
Cairo 5
Catanzaro 5
Curitiba 5
Düsseldorf 5
Totale 4.133
Nome #
Serum amyloid A: a new biomarker in Idiopathic Pulmonary Fibrosis 460
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 440
An explainable model of host genetic interactions linked to COVID-19 severity 386
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 290
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 283
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 275
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 263
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 252
Serum amyloid A in patients with idiopathic pulmonary fibrosis 246
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 245
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 230
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 229
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 217
Serum amyloid A: A potential biomarker of lung disorders 210
Effects of rituximab therapy on B cell differentiation and depletion 197
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 188
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 187
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 178
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 168
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 165
Serum Amyloid A in lung transplantation 147
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital. 142
Author reply 118
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases (Clinical and Experimental Medicine, (2020), 20, 2, (207-216), 10.1007/s10238-020-00608-5) 108
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis 82
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica. 77
Eterogeneità clinica e radiologica della sarcoidosi: case report di sarcoidosi sistemica con coinvolgimento osseo con aspetti di malignità. 64
Role of EBUS-TBNA in interstitial lung diseases: a case report of lymphangitis carcinomatosa. 63
A case report on expanding horizon of endobronchial ultrasound through esophagus 63
SAA and lipid metabolism in IPF 60
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 58
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 52
The thin line between sarcoidosis and cancer: can we consider PET as an oncologic screening tool in radiologically stable and asymptomatic sarcoidosis? 52
Biomarkers of Response to Nintedanib in IPF 51
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 48
Atipical radiological NSIP pattern in GLILD: a case report 46
FINDING BAL EOSINOPHILIA IN DESQUAMATIVE INTERSTITIAL PNEUMONIA 46
A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report. 44
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 42
Sarcoidosis and Autoimmune Inflammatory Syndrome Induced by Adjuvants: a case report. 39
Chilotorace maligno: patogenesi e valore prognostico. 36
MYASTHENIA GRAVIS IN INTERSTITIAL LUNG DISEASE DUE TO RHEUMATOID ARTHRITIS: A RARE COMORBIDITY TO CONSIDER. 34
TH-2 INFLAMMATION: A COMMON PATHWAY BETWEEN UIP PATTERN PULMONARY FIBROSIS AND HYPEREOSINOPHILIC SYNDROME 24
Serum Amyloid A and Lipid Metabolism in Idiopathic Pulmonary Fibrosis: A New Target for Antifibrotic Therapy? 20
Totale 6.625
Categoria #
all - tutte 20.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 52 35 26 8 5 14 11 12 47 33 62
2022/2023466 25 52 35 40 27 79 31 57 53 30 30 7
2023/2024589 21 22 63 10 17 142 152 28 4 14 18 98
2024/20251.116 99 50 115 55 132 45 42 50 89 58 123 258
2025/20262.984 219 369 294 361 569 112 282 126 120 205 116 211
2026/2027252 141 111 0 0 0 0 0 0 0 0 0 0
Totale 6.625